— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.
Check below Quest Diagnostics Q3 2019 earnings infograph
— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.
— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.
— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.
— For fiscal 2019, revenue is expected to be approximately $7.72 billion.
— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.
— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.
Most Popular
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is expected to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
